Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | FP-1305 |
Synonyms | |
Therapy Description |
FP-1305 is a humanized IgG4 antibody that targets the scavenger receptor Clever-1 on tumor-associated macrophages, which may lead to and may lead to immune cell activation (J. Clin. Onc., 2020, 38(15), pp.3097). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
FP-1305 | FP1305|FP 1305|Clevegen|Bexmarilimab | FP-1305 is a humanized IgG4 antibody that targets the scavenger receptor Clever-1 on tumor-associated macrophages, which may lead to and may lead to immune cell activation (J. Clin. Onc., 2020, 38(15), pp.3097). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03733990 | Phase Ib/II | FP-1305 | A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS) | Recruiting | USA | FRA | ESP | 3 |